XHKG
1518
Market cap12mUSD
Oct 07, Last price
0.20HKD
1D
5.26%
1Q
-50.00%
IPO
-97.28%
Name
New Century Healthcare Holding Co Ltd
Chart & performance
P/E
—
P/S
0.14
EPS
—
Div yield, %
11.05%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
3.19%
Revenues
600m
-29.11%
Net income
-115m
L
CFO
18m
-86.81%
Dividend
May 29, 20250.0221 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
New Century Healthcare Holding Co. Limited functions as an investment enterprise, providing medical services specifically designed for women and children throughout the People's Republic of China. Its principal activities include specialized care in paediatrics, obstetrics, and gynaecology, complemented by hospital advisory services. Furthermore, the company offers digital healthcare solutions and operates on-site amenities like cafeterias and gift shops within its medical facilities. This entity was founded in 2002 and maintains its headquarters in Beijing, China.
Key people
Jason Zhou
Executive Chairman of the Board, Chief Executive Officer · since 2015
Lan Teng
Chief Executive Officer of BNC Womens and Childrens Hospital · since 2021
Xiaofeng Jia
Vice President, Company Secretary · since 2021
Hong Zhou
Chief Physician, Vice President, Chief Medical Officer · since 2016
Hong Xin
Chief Operating Officer, Senior Vice President, Executive Director · since 2016
Han Xu
Chief Financial Officer, Senior Vice President, Executive Director · since 2016
Suyu Li
Non-Executive Director · since 2022
Siye Wang
Non-Executive Director · since 2016
Qiang Xie
Non-Executive Director · since 2021
Yuelin Yang
Non-Executive Director · since 2018
Non-Executive Independent Director · since 2016
Jing Ma
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2016
Guanxiong Wu
Non-Executive Independent Director · since 2016
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||